BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 32828969)

  • 1. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease.
    Pantiya P; Thonusin C; Chattipakorn N; Chattipakorn SC
    Mitochondrion; 2020 Nov; 55():14-47. PubMed ID: 32828969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
    Olesen MA; Villavicencio-Tejo F; Quintanilla RA
    Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
    Tabassum R; Jeong NY
    Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia.
    Schapira AH
    Biochim Biophys Acta; 1999 Feb; 1410(2):159-70. PubMed ID: 10076024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mtDNA mutations and common neurodegenerative disorders.
    Howell N; Elson JL; Chinnery PF; Turnbull DM
    Trends Genet; 2005 Nov; 21(11):583-6. PubMed ID: 16154228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Biology and Neurological Diseases.
    Arun S; Liu L; Donmez G
    Curr Neuropharmacol; 2016; 14(2):143-54. PubMed ID: 26903445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioenergetic and oxidative stress in neurodegenerative diseases.
    Bowling AC; Beal MF
    Life Sci; 1995; 56(14):1151-71. PubMed ID: 7475893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA damage and repair in neurodegenerative disorders.
    Yang JL; Weissman L; Bohr VA; Mattson MP
    DNA Repair (Amst); 2008 Jul; 7(7):1110-20. PubMed ID: 18463003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
    Hroudová J; Singh N; Fišar Z
    Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases.
    Qi Z; Huang Z; Xie F; Chen L
    J Cell Physiol; 2019 Jul; 234(7):10032-10046. PubMed ID: 30515821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Ca
    Naia L; Ferreira IL; Ferreiro E; Rego AC
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1069-1077. PubMed ID: 27485547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.